Bio-regeneration: safety in complex biology
REPORT summary
Patient
A 54-year-old woman (Fitzpatrick III) with superficial fat deflation and poor skin elasticity had shown limited improvement after several high-volume BDDE-HA treatments.
Results
The treatment proved more effective, with excellent biointegration and a high safety profile in Hashimoto patients, thanks to the absence of inflammatory responses. By stimulating fibroblasts and collagen I/III production, Neauvia Stimulate promoted true bioregeneration, even in delicate, autoimmune-compromised skin.
Treatments
Switching to Neauvia Stimulate (PEGHA 26 mg/ml with CaHA) resulted in clear redefinition of fat compartments, improved skin quality, and long-lasting effects.
discover more
CLINICAL CASES
want to know more about
our treatments?
Neauvia products are for trained experts only. Use must follow approved indications and the Instructions for Use (IFU) in accordance to applicable laws and regulations in each country. Physicians are solely responsible for any treatments outside these conditions. The results shown are specific to an individual treatment plan. Treatment decisions must be adapted to each patient, who may respond differently based on numerous factors. Outcomes are variable and not guaranteed.